Learning-Based sensitivity analysis and feedback design for drug delivery of mixed therapy of cancer in the presence of high model uncertainties

• URL: http://arxiv.org/abs/2205.07482v1
• Date: Mon, 16 May 2022 07:08:50 GMT
• Title: Learning-Based sensitivity analysis and feedback design for drug delivery of mixed therapy of cancer in the presence of high model uncertainties
• Authors: Mazen Alamir
• Abstract summary: It is shown that dash-boards can be built in the 2D-space of the most influent state components that summarize the outcomes' probabilities and the associated drug usage as iso-values curves in the reduced state space. It is shown that dash-boards can be built in the 2D-space of the most influent state components that summarize the outcomes' probabilities and the associated drug usage as iso-values curves in the reduced state space.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-nc-sa/4.0/
• Abstract: In this paper, a methodology is proposed that enables to analyze the sensitivity of the outcome of a therapy to unavoidable high dispersion of the patient specific parameters on one hand and to the choice of the parameters that define the drug delivery feedback strategy on the other hand. More precisely, a method is given that enables to extract and rank the most influent parameters that determine the probability of success/failure of a given feedback therapy for a given set of initial conditions over a cloud of realizations of uncertainties. Moreover predictors of the expectations of the amounts of drugs being used can also be derived. This enables to design an efficient stochastic optimization framework that guarantees safe contraction of the tumor while minimizing a weighted sum of the quantities of the different drugs being used. The framework is illustrated and validated using the example of a mixed therapy of cancer involving three combined drugs namely: a chemotherapy drug, an immunology vaccine and an immunotherapy drug. Finally, in this specific case, it is shown that dash-boards can be built in the 2D-space of the most influent state components that summarize the outcomes' probabilities and the associated drug usage as iso-values curves in the reduced state space.

Related papers

• Non-Linear Self Augmentation Deep Pipeline for Cancer Treatment outcome Prediction [7.455416595124159]
  Authors present an innovative strategy that harnesses a non-linear cellular architecture in conjunction with a deep downstream classifier. This approach aims to carefully select and enhance 2D features extracted from chest-abdomen CT images, thereby improving the prediction of treatment outcomes. The proposed pipeline has been meticulously designed to seamlessly integrate with an advanced embedded Point of Care system.
  arXiv  Detail & Related papers  (2023-07-26T15:01:26Z)
• A Decision Making Approach for Chemotherapy Planning based on Evolutionary Processing [0.0]
  In this paper, a multi-objective meta-heuristic method is provided for cancer chemotherapy. The proposed method uses mathematical models in order to measure the drug concentration, tumor growth and the amount of toxicity. Results show that the proposed method achieve to a better therapeutic performance compared to a more recent similar method.
  arXiv  Detail & Related papers  (2023-03-19T02:26:50Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• Probabilistic feature extraction, dose statistic prediction and dose mimicking for automated radiation therapy treatment planning [0.5156484100374058]
  We propose a framework for quantifying predictive uncertainties of dose-related quantities. This information can be leveraged in a dose mimicking problem in the context of automated radiation therapy treatment planning.
  arXiv  Detail & Related papers  (2021-02-24T21:35:44Z)
• Clinical Outcome Prediction from Admission Notes using Self-Supervised Knowledge Integration [55.88616573143478]
  Outcome prediction from clinical text can prevent doctors from overlooking possible risks. Diagnoses at discharge, procedures performed, in-hospital mortality and length-of-stay prediction are four common outcome prediction targets. We propose clinical outcome pre-training to integrate knowledge about patient outcomes from multiple public sources.
  arXiv  Detail & Related papers  (2021-02-08T10:26:44Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)
• A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases [60.07352590494571]
  The aim of this study was to extend this approach to the observational setting using a standardized scalable framework. We demonstrate our framework by evaluating the effect of angiotensin-converting enzyme (ACE) inhibitors versus beta blockers on three efficacy and six safety outcomes.
  arXiv  Detail & Related papers  (2020-10-13T14:48:31Z)
• Kernel Assisted Learning for Personalized Dose Finding [20.52632915107782]
  An individualized dose rule recommends a dose level within a continuous safe dose range based on patient level information. In this article, we propose a kernel assisted learning method for estimating the optimal individualized dose rule.
  arXiv  Detail & Related papers  (2020-07-19T23:03:26Z)
• Learning for Dose Allocation in Adaptive Clinical Trials with Safety Constraints [84.09488581365484]
  Phase I dose-finding trials are increasingly challenging as the relationship between efficacy and toxicity of new compounds becomes more complex. Most commonly used methods in practice focus on identifying a Maximum Tolerated Dose (MTD) by learning only from toxicity events. We present a novel adaptive clinical trial methodology that aims at maximizing the cumulative efficacies while satisfying the toxicity safety constraint with high probability.
  arXiv  Detail & Related papers  (2020-06-09T03:06:45Z)
• Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncology [0.0]
  Current strategies comprise model-informed dosing tables or are based on maximum a-posteriori estimates. We propose three novel approaches for MIPD employing Bayesian data assimilation and/or reinforcement learning to control neutropenia. These approaches have the potential to substantially reduce the incidence of life-threatening grade 4 and subtherapeutic grade 0 neutropenia.
  arXiv  Detail & Related papers  (2020-06-01T16:38:27Z)
• Contextual Constrained Learning for Dose-Finding Clinical Trials [102.8283665750281]
  C3T-Budget is a contextual constrained clinical trial algorithm for dose-finding under both budget and safety constraints. It recruits patients with consideration of the remaining budget, the remaining time, and the characteristics of each group.
  arXiv  Detail & Related papers  (2020-01-08T11:46:48Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.